Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382:727–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Worobey M, Levy JI, Malpica Serrano L, Crits-Christoph A, Pekar JE, Goldstein SA, et al. The Huanan Seafood Wholesale Market in Wuhan was the early epicenter of the COVID-19 pandemic. Science (80-). 2022;377:951–9.

Article  CAS  Google Scholar 

Gostin LO, Gronvall GK. The Origins of Covid-19 — Why It Matters (and Why It Doesn’t). N Engl J Med. 2023;388:2305–8.

Article  PubMed  Google Scholar 

WHO WHO. COVID-19 Weekly Epidemiological Update, Edition 150. 2023. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---6-july-2023 (accessed 13 Jul 2023).

Hu B, Guo H, Zhou P, Shi Z-L. Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol. 2021;19:141–54.

Article  CAS  PubMed  Google Scholar 

Ioannidis JPA. Infection fatality rate of COVID-19 inferred from seroprevalence data. Bull World Health Organ. 2021;99:19–33F.

Article  PubMed  Google Scholar 

Bunders MJ, Altfeld M. Implications of sex differences in immunity for SARS-CoV-2 pathogenesis and design of therapeutic interventions. Immunity. 2020;53:487–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yehia BR, Winegar A, Fogel R, Fakih M, Ottenbacher A, Jesser C, et al. Association of race with mortality among patients hospitalized with Coronavirus disease 2019 (COVID-19) at 92 US Hospitals. JAMA Netw Open. 2020;3:e2018039.

Article  PubMed  PubMed Central  Google Scholar 

Maroko AR, Nash D, Pavilonis BT. COVID-19 and inequity: a comparative spatial analysis of New York City and Chicago Hot Spots. J Urban Heal. 2020;97:461–70.

Article  Google Scholar 

Rydyznski Moderbacher C, Ramirez SI, Dan JM, Grifoni A, Hastie KM, Weiskopf D, et al. Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell. 2020;183:996–1012.e19.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brannock MD, Chew RF, Preiss AJ, Hadley EC, Redfield S, McMurry JA, et al. Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program. Nat Commun. 2023;14:2914.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Davis HE, McCorkell L, Vogel JM, Topol EJ. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol. 2023;21:133–46.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Notarte KI, Catahay JA, Velasco JV, Pastrana A, Ver AT, Pangilinan FC, et al. Impact of COVID-19 vaccination on the risk of developing long-COVID and on existing long-COVID symptoms: a systematic review. eClinicalMedicine. 2022;53:101624.

Article  PubMed  PubMed Central  Google Scholar 

Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181:271–80.e8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science (80-). 2020;367:1260–3.

Article  CAS  Google Scholar 

Cai Y, Zhang J, Xiao T, Peng H, Sterling SM, Walsh RM, et al. Distinct conformational states of SARS-CoV-2 spike protein. Science (80-). 2020;369:1586–92.

Article  CAS  Google Scholar 

Greaney AJ, Loes AN, Crawford KHD, Starr TN, Malone KD, Chu HY, et al. Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host Microbe. 2021;29:463–76.e6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Piccoli L, Park Y-J, Tortorici MA, Czudnochowski N, Walls AC, Beltramello M, et al. Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell. 2020;183:1024–42.e21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rogers TF, Zhao F, Huang D, Beutler N, Burns A, He W, et al. Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science (80-). 2020;369:956–63.

Article  CAS  Google Scholar 

Zost SJ, Gilchuk P, Chen RE, Case JB, Reidy JX, Trivette A, et al. Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein. Nat Med. 2020;26:1422–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu H, Wilson IA. Protective neutralizing epitopes in SARS‐CoV‐2. Immunol Rev. 2022;310:76–92.

Article  CAS  PubMed  Google Scholar 

Dejnirattisai W, Zhou D, Ginn HM, Duyvesteyn HME, Supasa P, Case JB, et al. The antigenic anatomy of SARS-CoV-2 receptor binding domain. Cell. 2021;184:2183–2200.e22.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chi X, Yan R, Zhang J, Zhang G, Zhang Y, Hao M, et al. A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2. Science (80-). 2020;369:650–5.

Article  CAS  Google Scholar 

McCallum M, De Marco A, Lempp FA, Tortorici MA, Pinto D, Walls AC, et al. N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell. 2021;184:2332–47.e16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Poh CM, Carissimo G, Wang B, Amrun SN, Lee CY-P, Chee RS-L, et al. Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients. Nat Commun. 2020;11:2806.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Peter AS, Roth E, Schulz SR, Fraedrich K, Steinmetz T, Damm D, et al. A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS‐CoV‐2 infection model. Eur J Immunol. 2022;52:770–83.

Article  CAS  PubMed  Google Scholar 

Brouwer PJM, Caniels TG, van der Straten K, Snitselaar JL, Aldon Y, Bangaru S, et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science (80-). 2020;369:643–50.

Article  CAS  Google Scholar 

Song G, He W, Callaghan S, Anzanello F, Huang D, Ricketts J, et al. Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection. Nat Commun. 2021;12:2938.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pinto D, Sauer MM, Czudnochowski N, Low JS, Tortorici MA, Housley MP, et al. Broad betacoronavirus neutralization by a stem helix–specific human antibody. Science (80-). 2021;373:1109–16.

Article  CAS  Google Scholar 

Zhou P, Yuan M, Song G, Beutler N, Shaabani N, Huang D et al. A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection. Sci Transl Med. 2022; 14. https://doi.org/10.1126/scitranslmed.abi9215.

Dacon C, Tucker C, Peng L, Lee C-CD, Lin T-H, Yuan M, et al. Broadly neutralizing antibodies target the coronavirus fusion peptide. Science (80-). 2022;377:728–35.

Article  CAS  Google Scholar 

McCallum M, Czudnochowski N, Rosen LE, Zepeda SK, Bowen JE, Walls AC, et al. Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement. Science (80-). 2022;375:864–8.

Article  CAS  Google Scholar 

Viana R, Moyo S, Amoako DG, Tegally H, Scheepers C, Althaus CL, et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature. 2022;603:679–86.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N Engl J Med. 2021;384:403–16.

Article  CAS  PubMed  Google Scholar 

Sadoff J, Gray G, Vandebosch A, Cárdenas V, Shukarev G, Grinsztejn B, et al. Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19. N Engl J Med. 2021;384:2187–201.

Article  CAS  PubMed  Google Scholar 

Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–15.

Article  CAS  PubMed  Google Scholar 

Voysey M, Clemens